This inventor holds 2 USPTO granted patents. Top assignees: Boehringer Ingelheim Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 1982-1992.
Company Filing History:
1 out of 306 
1 out of 278 
Years Active: 1982-1992
Title: Victor Fuchs: Innovator in Pharmaceutical Chemistry
Introduction
Victor Fuchs is a notable inventor based in New Fairfield, CT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. With a total of 2 patents, his work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents are the Imidazo[1,2-a]piperazines, which are inhibitors of human neutrophil elastase. These compounds are characterized by a specific general structure, with substituents defined in the patent documentation. Another significant patent is for Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones, which includes compounds where R1 can be hydrogen, halogen, or methoxy.
Career Highlights
Victor has worked with prominent companies in the pharmaceutical industry, including Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas.
Collaborations
Throughout his career, Victor has collaborated with esteemed colleagues such as James T. Oliver and Kurt Freter. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Victor Fuchs is a distinguished inventor whose work in pharmaceutical chemistry continues to influence the industry. His patents reflect his commitment to innovation and the pursuit of new therapeutic solutions.